Dapagliflozin (5mg), Vildagliptin SR (50mg) .............

Dapagliflozin (5mg), Vildagliptin SR (50mg)
DAPA VILDA 50/5  
Dapagliflozin is a medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor.
It works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the urine back into the bloodstream. By inhibiting SGLT2, dapagliflozin increases the excretion of glucose in the urine, leading to a decrease in blood glucose levels.
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1. Incretin hormones help regulate blood sugar by stimulating the release of insulin and reducing the secretion of glucagon, a hormone that raises blood sugar levels.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/dapa-vilda-50-5-134374